Press/Media
- 350 - 375 out of 882 results
Search results
-
-
Weekly: Biohaven Pharmaceutical Holding (BHVN: $30.44) up 6% in 2 weeks; +78c [2.6%]
27/11/23
1 item of Media coverage
Press/Media
-
Weekly: Biohaven Pharmaceutical Holding (BHVN: $30.44) up 6% in 2 weeks; +78c [2.6%]
25/11/23
1 item of Media coverage
Press/Media
-
Two-bagger Biohaven Pharmaceutical Holding (BHVN: $30.09) climbs 5%; +$1.49 [5.2%]
18/11/23
1 item of Media coverage
Press/Media
-
-
-
Oklahoma Legislature's Mental Health Caucus hosts workforce Interim Study
10/11/23
1 item of Media coverage
Press/Media
-
-
-
-
Oklahoma behavioral health experts say ‘bold steps’ needed to invest in future workforce
9/11/23
1 item of Media coverage
Press/Media
-
Oklahoma behavioral health experts say ‘bold steps’ needed to invest in future workforce
8/11/23
1 item of Media coverage
Press/Media
-
Oklahoma behavioral health experts say ‘bold steps’ needed to invest in future workforce
8/11/23
1 item of Media coverage
Press/Media
-
Saint Francis breaks ground on psychiatric hospital expansions
7/11/23
1 item of Media coverage
Press/Media
-
Monthly: Biohaven Pharmaceutical Holding (BHVN: $26.51) up 45% in 2 months
6/11/23
1 item of Media coverage
Press/Media
-
Two-bagger Biohaven Pharmaceutical Holding (BHVN: $30.82) surges 15%; +$3.98 [14.8%]
4/11/23
1 item of Media coverage
Press/Media
-
-
-
Monthly: Collegium Pharmaceutical (COLL: $21.76) falls for a second consecutive month, a two-month fall of 7%
1/11/23
1 item of Media coverage
Press/Media
-
UK researchers awarded $2.6 million to study new drug combination driving overdose deaths
1/11/23
1 item of Media coverage
Press/Media
-
Monthly: Biohaven Pharmaceutical Holding (BHVN: $26.51) up 45% in 2 months
1/11/23
1 item of Media coverage
Press/Media